Walleye Capital LLC Invests $522,000 in Quanterix Co. (NASDAQ:QTRX)

Walleye Capital LLC acquired a new stake in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 49,121 shares of the company's stock, valued at approximately $522,000. Walleye Capital LLC owned 0.13% of Quanterix as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of Quanterix by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company's stock worth $23,569,000 after purchasing an additional 19,386 shares during the last quarter. William Blair Investment Management LLC bought a new stake in Quanterix during the 4th quarter valued at about $11,290,000. Easterly Investment Partners LLC boosted its position in Quanterix by 9.0% in the 4th quarter. Easterly Investment Partners LLC now owns 954,995 shares of the company's stock valued at $10,152,000 after buying an additional 78,862 shares during the period. Geode Capital Management LLC grew its stake in Quanterix by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 863,503 shares of the company's stock worth $9,181,000 after acquiring an additional 4,836 shares in the last quarter. Finally, State Street Corp increased its position in shares of Quanterix by 2.2% during the third quarter. State Street Corp now owns 836,443 shares of the company's stock worth $10,840,000 after acquiring an additional 18,050 shares during the period. Hedge funds and other institutional investors own 86.48% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Scotiabank reiterated an "outperform" rating on shares of Quanterix in a report on Tuesday, March 25th. Canaccord Genuity Group dropped their price target on Quanterix from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Tuesday, March 18th.

Quanterix Stock Performance

NASDAQ QTRX opened at $5.16 on Wednesday. The company has a market cap of $200.15 million, a PE ratio of -4.87 and a beta of 1.35. The firm's 50 day moving average price is $6.69 and its 200-day moving average price is $9.66. Quanterix Co. has a 52-week low of $4.67 and a 52-week high of $19.18.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its earnings results on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The company had revenue of $35.16 million for the quarter, compared to the consensus estimate of $34.93 million. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. On average, analysts forecast that Quanterix Co. will post -0.98 earnings per share for the current fiscal year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.